Market capitalization (market cap) is the market value of a publicly traded company’s outstanding shares. Market capitalization is equal to the share price multiplied by the number of shares outstanding. As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company’s net worth and is a determining factor in some forms of stock valuation.
Market capitalization refers to the total dollar market value of a company’s outstanding shares. Commonly referred to as “market cap,” it is calculated by multiplying a company’s shares outstanding by the current market price of one share. The investment community uses this figure to determine a company’s size, as opposed to using sales or total asset figures.
Important Factors to Watch:
On 29-11-2019 (Friday), Shares of Arrowhead Pharmaceuticals, Inc., (NASDAQ: ARWR) displayed a change of 5.78 after which it closed the day’ session at $73.01. The volume amounted to 2051328 shares which compares with the average volume of 1.67M shares. Arrowhead Pharmaceuticals, Inc., a USA based Company, belongs to Healthcare sector and Biotechnology industry. The shares of Arrowhead Pharmaceuticals, Inc. was among the active stocks of the last trading sessions.
The stock price moved with change of 1.8113 to its 50 Day low point and changed 0.0388 comparing to its 50 Day high point. ARWR stock is currently showing down return of 48.82 throughout last week and witnessed bearish return of 82.39 in one month period. The performance of company 113.67 in three months and 199.1 for the last six months trading period.
The stock price volatility remained at 6.66 in recent month and reaches at 10.2 for the week. The Average True Range (ATR) is also a measure of volatility is currently sitting at 3.86. The stock touched its 52-Week High on and 52-Week Low on . The firm shows the market capitalization of $6.86B.
Arrowhead Pharmaceuticals, Inc. has P/S value of 50.12 while its P/B value stands at 30.68. Similarly, the company has Return on Assets of 16.2, Return on Equity of 26.2 and Return on Investment of -57. The company shows Gross Margin and Operating Margin of and respectively.
Forward P/E of Arrowhead Pharmaceuticals, Inc. is standing at . Forward P/E is a measure of the price-to-earnings ratio using forecasted earnings for the P/E calculation for the next fiscal year.
Notable Indicators to Watch:
ARWR institutional ownership is held at 72.7% while insider ownership was 2.8%. Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. Institutions generally purchase large blocks of a company’s outstanding shares and can exert considerable influence upon its administration.
Many value shareholders look for stocks with a high percentage of insider ownership, under the theory that when administration is shareholders, they will act in its own self-interest, and create shareholder value in the long-term.